Serologicals last week named Michael Monko as vice president of sales for its research products segment. Monko previously spent 20 years in various sales positions at Invitrogen. He most recently served as Invitrogen's senior director of sales force effectiveness. He holds an MBA from Babson College and a BS in biochemistry from the University of New Hampshire. Monko will be based in Serologicals' Temecula, Calif., office.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.